Literature DB >> 2515920

Ganglioside composition of astrocytes.

H Asou1, S Hirano, K Uyemura.   

Abstract

Short-term and long-term (greater than 7 months) cultured astrocytes from 14-day-old rat brain were analyzed for ganglioside content. Analysis of the extracted gangliosides by HPTLC revealed that ganglioside GM1 was absent in 35 days and 235 days cultured astrocytes, and that the predominant ganglioside was GM3, showing a double band in both cases. A small amount of the disialogangliosides (GD3, GD1a) was also detected. More than 70% of radioactivities into ganglioside fractions by cultured astrocytes, in the presence of N-[3H]-acetylmannosamine, appeared in ganglioside GM3. The upper band component of GM3 increased 60% in long-term astrocyte cultures compared to 35-day-old cultures. Also, an increased GD3 content in long-term astrocyte cultures was detected. These results suggest that the increase of GD3 and upper band GM3 in long-term cultured astrocytes might be related to the appearance of small processes showing strong reactivity against GFAP and vimentin during astrocyte-subculture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515920     DOI: 10.1247/csf.14.561

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  5 in total

1.  Developmental changes in gangliosides in cultured cerebellar granule neurons.

Authors:  W Thangnipon; R Balázs
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

2.  Plasma membrane-associated glycohydrolases along differentiation of murine neural stem cells.

Authors:  Massimo Aureli; Angela Gritti; Rosaria Bassi; Nicoletta Loberto; Alessandra Ricca; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  Neurochem Res       Date:  2012-02-16       Impact factor: 3.996

3.  Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide.

Authors:  Nouara Yahi; Jacques Fantini
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

Review 4.  Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.

Authors:  Nouara Yahi; Coralie Di Scala; Henri Chahinian; Jacques Fantini
Journal:  Glycoconj J       Date:  2021-07-30       Impact factor: 2.916

5.  Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity.

Authors:  Oeystein R Brekk; Joanna A Korecka; Cecile C Crapart; Mylene Huebecker; Zachary K MacBain; Sara Ann Rosenthal; Miguel Sena-Esteves; David A Priestman; Frances M Platt; Ole Isacson; Penelope J Hallett
Journal:  Acta Neuropathol Commun       Date:  2020-08-06       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.